Pharmaron’s radiochemistry team (formerly Quotient Bioresearch/GE Health/Amersham) provides our partners with expert advice on radiochemical synthesis design, position of the radiolabel and preparation and release of labelled test compounds for use in non-clinical and clinical drug development and in environmental fate studies. With over 75 years of radiochemical synthesis history, we have made 70,000 14C labelled and 20,000 3H labelled molecules. Our state-of-the-art facilities include GMP and GLP compliant laboratories in which hundreds of radiolabelled chemical synthesis projects are completed annually.